查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2095714

腎臟及泌尿系統醫療設備市場－2026-2032年全球市場預測

Nephrology & Urology Devices Market - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，腎臟和泌尿系統醫療設備市場規模將成長至 301.4 億美元，複合年成長率為 6.52%。

主要市場統計數據
基準年 2025 193.7億美元
預計年份：2026年 206億美元
預測年份 2032 301.4億美元
複合年成長率 (%) 6.52%

腎臟和泌尿系統醫療設備用於輔助診斷、監測、治療和長期管理腎臟、泌尿系統、前列腺、膀胱和生殖系統疾病。市場需求受多種臨床和人口因素的影響，包括人口老化、慢性腎臟病負擔加重、糖尿病和高血壓盛行率上升、尿道結石、良性前列腺增生、尿失禁和泌尿器官系統癌症。公共衛生證據始終表明，慢性腎臟病與心血管疾病風險、糖尿病和高血壓密切相關，而泌尿器官系統疾病仍然是門診就診、住院和生活品質下降的常見原因。

醫療設備領域涵蓋透析機及耗材、輸尿管支架、尿道導管、體外震波碎石機、內視鏡、尿液動力學監測系統、腎臟造瘻產品、引流系統、失禁護理設備、前列腺治療技術以及機器人輔助或影像導引手術平台。在醫療保健系統中，早期診斷、微創治療、感染預防、居家護理以及利用數位科技的診療路徑是優先考慮的因素。因此，腎臟和泌尿系統醫療設備的創新越來越注重病患安全、簡化臨床工作流程、遠端監測、生物相容性材料、手術精準性以及在不影響治療效果的前提下降低整體醫療成本。

腎臟和泌尿系統醫療設備領域的變革性變化。

隨著醫療保健模式從以醫院為中心的介入轉向整合式、微創式和門診模式，腎臟和泌尿系統醫療設備領域正在經歷結構性變革。在腎臟病學領域，家庭透析計畫的擴展、穿戴式和可攜式腎臟護理設備的探索、水處理系統的改進以及遠端患者監護正在改變慢性腎臟病和腎衰竭的治療方式。這些變革旨在滿足持續照護的需求、降低感染風險、提高患者自主性以及更有效地利用臨床資源。

人工智慧（AI）的累積影響

人工智慧 (AI) 透過改善影像診斷、治療計劃、病患監測、風險預測和工作流程自動化，正對腎臟病學和泌尿系統的醫療設備產生整體累積的影響。在腎臟病學領域，當人工智慧驅動的分析與電子健康記錄、實驗室數據和連網透析系統整合時，可以幫助早期發現腎功能下降、監測透析的適宜性、監測血管通路、進行液體管理以及評估住院風險。當這些應用能夠輔助臨床決策並在檢驗的管治框架內運作時，其價值才能得到最大程度的體現。

對關鍵區域的洞察

亞太地區是腎臟和泌尿系統醫療設備最具活力的地區之一，這主要得益於人口快速老化、糖尿病和高血壓盛行率上升、醫療基礎設施不斷完善以及微創治療的普及。中國、印度、日本、韓國、澳洲和東南亞國協的醫療衛生系統正在投資透析設施、內視鏡泌尿系統平台、影像導引輔助手術、數位化醫院以及在地化生產能力。公立和私立醫療機構也在努力改善慢性腎臟病的治療和泌尿系統專科診療服務，但保險報銷差異、人員短缺以及區域間醫療資源分配不均等問題仍然是阻礙因素。

關鍵小組洞察

儘管北約成員國並非單一的醫療集團，但它們擁有許多先進的醫療保健系統。對於民用和國防醫療機構中使用的聯網腎臟和泌尿系統醫療設備而言，採購彈性、網路安全、供應鏈安全和標準化日益重要。七國集團（G7）在臨床創新、醫保報銷方案設計、品質標準以及人工智慧診斷、機器人輔助和微創泌尿外科治療和居家腎臟護理的早期應用方面仍然發揮著重要作用。金磚國家疾病負擔沉重、患者群體龐大且醫療保健投資不斷成長，因此在擴充性的透析解決方案、經濟高效的泌尿系統泌尿系統醫療設備、本地化生產和公共部門醫療服務支援計劃方面發揮關鍵作用。

主要國家的概況

中國正大力提升腎臟護理、泌尿系統專科、本土醫療設備製造和數位化醫院基礎設施的能力，以應對人口老化、慢性病和都市區醫療保健需求。美國憑藉其龐大的專科醫療網路、門診手術基礎設施、居家透析項目以及積極應用機器人輔助和影像引導泌尿系統手術，引領先進腎臟和泌尿系統醫療設備器械的普及應用。在日本，隨著人口老化和醫療體系的成熟，先進的泌尿功能照護、透析品質的提升、泌尿系統內視鏡檢查和精準醫療技術正得到大力推廣。在印度，透析、腎臟病篩檢、結石治療和價格合理的泌尿系統醫療設備存在著巨大的未滿足需求，而這些需求的普及應用受到公私合營醫療模式、成本敏感性和專科醫生就診管道增加等因素的影響。

為行業領導者提供的實用建議

業界領導者應優先考慮經臨床驗證、能夠解決腎臟和泌尿系統護理中可衡量挑戰的創新技術，例如：減少感染疾病、提高治療精準度、提升手術效率、增強患者舒適度、實現居家照護以及確保醫療設備的長期可靠性。產品開發必須與臨床醫生的工作流程、保險報銷的實際情況、消毒要求以及各大監管機構對證據的期望相契合。能夠減少併發症、支援遠端監測並提升專家和患者使用便利性的醫療設備更有可能成為市場上的長期穩定產品。

調查方法

本執行摘要採用系統性的二手研究途徑編寫，並專注於檢驗的公共衛生、監管、臨床和產業資訊來源。研究內容包括同行評審的醫學文獻、臨床實踐指南、公共衛生機構出版刊物、疾病負擔研究、法律規範、衛生技術評估 (HTA) 參考資料、醫院採購考慮以及腎臟和泌尿系統醫療服務提供方面的已驗證趨勢。分析著重強調了實證促進因素，例如慢性腎臟病盛行率、糖尿病和高血壓負擔、人口老化、尿道結石、感染預防重點、透析服務可及性、微創手術普及率以及數位醫療的整合。

結論

隨著醫療機構應對日益嚴重的腎臟疾病、泌尿系統疾病、攝護腺疾病、泌尿道結石、尿失禁和泌尿系統癌症等疾病負擔，腎臟和泌尿系統醫療設備正成為現代醫學的核心。其最大的發展機會在於：更安全的手術、更早期的診斷、居家腎臟護理、微創治療、互聯監測、人工智慧驅動的決策以及感染預防。由於報銷體系、基礎設施、醫療機構、監管法規和財政能力等因素的影響，區域部署預計將持續存在差異，因此制定在地化策略至關重要。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章：腎臟及泌尿系統醫療設備市場：依產品分類

  • 導管
  • 透析設備
    • 連續性腎臟替代療法系統
    • 血液透析過濾器
    • 血液透析系統
    • 腹膜透析系統
  • 內視鏡
  • 破碎設備
  • 輸尿管支架

第8章：腎臟和泌尿系統醫療設備市場：依技術分類

  • 聲波技術
  • 電化學技術
  • 雷射技術
  • 超過濾技術

第9章：腎臟和泌尿系統醫療設備市場：按分銷管道分類

  • 直銷
  • 銷售代理
  • 線上銷售

第10章：腎臟與泌尿系統醫療設備市場：依應用領域分類

  • 腎衰竭管理
  • 腎結石清除
  • 攝護腺疾病
  • 尿失禁管理

第11章：腎臟與泌尿系統醫療設備市場：依最終用戶分類

  • 門診手術中心
  • 透析中心
  • 居家醫療
  • 醫院

第12章：腎臟和泌尿系統醫療設備市場：按地區分類

  • 亞太地區
  • 歐洲
  • 北美洲
  • 拉丁美洲
  • 非洲
  • 中東

第13章：腎臟與泌尿系統醫療設備市場：依類別分類

  • NATO
  • G7
  • BRICS
  • EU
  • ASEAN
  • GCC

第14章：腎臟及泌尿系統醫療設備市場：依國家分類

  • 中國
  • 美國
  • 日本
  • 印度
  • 德國
  • 英國
  • 澳洲
  • 法國
  • 韓國
  • 義大利
  • 加拿大
  • 俄羅斯
  • 巴西
  • 墨西哥
  • 西班牙

第15章 競爭格局

  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第16章：公司簡介

  • Ambu A/S
  • AngioDynamics, Inc.
  • Asahi Kasei Corporation
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Becton, Dickinson and Company
  • Biodex Medical Systems, Inc.
  • Boston Scientific Corporation
  • Coloplast A/S
  • Convatec Group plc
  • Cook Group Incorporated
  • DirexGroup Ltd.
  • EDAP TMS SA
  • Fresenius Medical Care AG & Co. KGaA
  • Hollister Incorporated
  • Karl Storz SE & Co. KG
  • Laborie Medical Technologies Corp.
  • Lepu Medical Technology（Beijing）Co., Ltd.
  • Medtronic plc
  • Merit Medical Systems, Inc.
  • Nipro Corporation
  • Olympus Corporation
  • Richard Wolf GmbH
  • Siemens Healthineers AG
  • Stryker Corporation
  • Teleflex Incorporated
  • Terumo Corporation
  • Urovision GmbH
Product Code: MRR-F927BA462957

The Nephrology & Urology Devices Market is projected to grow by USD 30.14 billion at a CAGR of 6.52% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 19.37 billion
Estimated Year [2026] USD 20.60 billion
Forecast Year [2032] USD 30.14 billion
CAGR (%) 6.52%

Nephrology and urology devices support diagnosis, monitoring, treatment, and long-term management of kidney, urinary tract, prostate, bladder, and reproductive-system conditions. Demand is being shaped by well-documented clinical and demographic pressures, including population aging, rising chronic kidney disease burden, diabetes and hypertension prevalence, urinary stone disease, benign prostatic hyperplasia, incontinence, and urologic cancers. Public health evidence consistently links chronic kidney disease with cardiovascular risk, diabetes, and hypertension, while urologic disorders remain common contributors to outpatient visits, hospital-based procedures, and quality-of-life impairment.

The device landscape spans dialysis equipment and consumables, ureteral stents, urinary catheters, lithotripsy systems, endoscopes, urodynamic systems, nephrostomy products, drainage systems, continence care devices, prostate treatment technologies, and robotic or image-guided surgical platforms. Healthcare systems are prioritizing earlier diagnosis, minimally invasive intervention, infection prevention, home-based therapy, and digitally enabled care pathways. As a result, innovation in nephrology and urology devices is increasingly centered on patient safety, clinical workflow efficiency, remote monitoring, biocompatible materials, procedure precision, and lower total cost of care without compromising outcomes.

Transformative Shifts in the Nephrology & Urology Device Landscape

The nephrology and urology devices landscape is undergoing structural transformation as care shifts from hospital-centered interventions toward integrated, minimally invasive, and outpatient-ready models. In nephrology, the expansion of home dialysis programs, wearable and portable kidney-care device research, improved water treatment systems, and remote patient monitoring are changing how chronic kidney disease and kidney failure are managed. These shifts respond to the need for continuity of care, reduced infection exposure, greater patient autonomy, and more efficient use of clinical capacity.

In urology, advances in flexible endoscopy, laser lithotripsy, digital imaging, single-use scopes, robotic assistance, and focal therapies are reshaping treatment of urinary stones, prostate disease, bladder conditions, and urologic cancers. Infection control remains a major driver, particularly for catheter-associated urinary tract infections and other device-related complications. Regulatory bodies and clinical guidelines continue to emphasize device sterility, traceability, patient risk stratification, and post-market surveillance. Sustainability is also emerging as a strategic priority, especially in high-volume dialysis and single-use device categories, where manufacturers and providers are evaluating waste reduction, energy efficiency, and responsible procurement.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is creating cumulative impact across nephrology and urology devices by improving image interpretation, procedural planning, patient monitoring, risk prediction, and workflow automation. In nephrology, AI-enabled analytics can support earlier identification of kidney function decline, dialysis adequacy monitoring, vascular access surveillance, fluid management, and hospitalization risk assessment when integrated with electronic health records, laboratory data, and connected dialysis systems. These applications are most valuable when they augment clinical decision-making and operate within validated governance frameworks.

In urology, AI is being applied to endoscopic image enhancement, stone recognition, prostate imaging support, bladder cancer detection workflows, robotic surgery assistance, urodynamic interpretation, and triage of hematuria or lower urinary tract symptoms. The impact is cumulative rather than isolated: better data capture improves algorithms, stronger algorithms improve clinical workflows, and improved workflows support more consistent patient outcomes. However, adoption depends on clinical validation, cybersecurity, interoperability, explainability, bias mitigation, and regulatory compliance. Industry leaders that treat AI as a regulated clinical capability rather than a standalone software feature are better positioned to build trust with physicians, patients, and health systems.

Key Regional Insights

Asia-Pacific is one of the most dynamic regions for nephrology and urology devices due to rapid population aging, rising diabetes and hypertension prevalence, expanding healthcare infrastructure, and growing access to minimally invasive care. China, India, Japan, South Korea, Australia, and ASEAN healthcare systems are investing in dialysis capacity, endourology platforms, imaging-guided procedures, digital hospitals, and localized manufacturing capabilities. Public and private providers are also improving access to chronic kidney disease management and urologic specialty services, although reimbursement variability, workforce shortages, and rural access gaps remain important constraints.

Europe is characterized by strict regulatory oversight, strong clinical guideline adherence, and broad uptake of minimally invasive urology, dialysis quality programs, and infection-control practices. The transition to the European medical device regulatory framework has increased documentation, clinical evidence, and post-market surveillance requirements, influencing product availability and development timelines. North America demonstrates strong adoption of advanced nephrology and urology technologies supported by established reimbursement pathways, specialist availability, clinical research activity, and mature hospital procurement systems. The United States and Canada continue to emphasize home dialysis, infection prevention, outpatient urologic procedures, robotic surgery, and digital health integration.

Latin America is seeing gradual improvement in access to dialysis services, stone management, and urologic diagnostics, with Brazil and Mexico acting as important healthcare hubs; however, uneven reimbursement, infrastructure limitations, and public-sector budget pressure influence adoption rates. Africa faces a high unmet need for kidney care and urologic intervention, with access shaped by workforce shortages, dialysis affordability, diagnostic gaps, and uneven distribution of specialist centers, creating demand for durable, cost-effective, and easy-to-maintain devices. The Middle East is expanding specialty care through tertiary hospitals, medical infrastructure investment, and demand for advanced urology and kidney care, particularly across Gulf countries where diabetes and hypertension management remains closely tied to kidney-care priorities.

Key Group Insights

NATO countries, while not a healthcare bloc, include many advanced medical systems where procurement resilience, cybersecurity, supply chain security, and standardization are increasingly relevant for connected nephrology and urology devices used in civilian and defense healthcare settings. The G7 remains influential in clinical innovation, reimbursement design, quality standards, and early adoption of AI-enabled diagnostics, robotic assistance, minimally invasive urology, and home-based kidney care. BRICS countries combine high disease burden, large patient populations, and increasing healthcare investment, making them important for scalable dialysis solutions, cost-efficient urology devices, local manufacturing, and public-sector access programs.

The European Union is a major regulatory and clinical evidence hub, with device adoption shaped by health technology assessment, procurement standards, sustainability objectives, and the requirements of the medical device regulatory framework. ASEAN countries are strengthening nephrology and urology care through expanding hospital networks, medical tourism, public health investment, and broader access to dialysis and endoscopic procedures. The region's diverse reimbursement systems and infrastructure maturity create varied adoption patterns, with urban centers typically leading in advanced urology platforms and chronic kidney disease services. The GCC is prioritizing high-acuity specialty hospitals, digital health infrastructure, and advanced surgical capabilities, supporting demand for premium urology systems, dialysis technologies, and integrated care pathways for diabetes- and hypertension-related kidney disease.

Key Country Insights

China is expanding kidney care capacity, urology specialization, local device manufacturing, and digital hospital infrastructure in response to aging, chronic disease, and urban healthcare demand. The United States leads adoption of advanced nephrology and urology devices through extensive specialty networks, outpatient surgical infrastructure, home dialysis initiatives, and strong use of robotic and image-guided urologic procedures. Japan's aging population and mature healthcare system support advanced continence care, dialysis quality, endoscopic urology, and precision technologies. India has a large unmet need for dialysis, kidney disease screening, stone management, and affordable urology devices, with adoption shaped by public-private care models, cost sensitivity, and expanding specialist access.

Germany benefits from advanced hospital infrastructure, strong engineering expertise, and broad availability of minimally invasive procedures, while the United Kingdom is focused on reducing waiting lists, improving outpatient pathways, and expanding diagnostic capacity for urologic disease and kidney care. Australia emphasizes high clinical standards, remote-care challenges, and chronic disease management, and France emphasizes regulated access, clinical evidence, and national care pathways. South Korea combines advanced hospital systems, strong technology adoption, and expertise in minimally invasive urologic procedures, while Italy and Spain combine aging populations with strong urology practice networks and demand for stone, prostate, continence, and dialysis solutions.

Canada emphasizes universal healthcare access, clinical guideline alignment, and quality-focused kidney care, with continued attention to home-based therapy and equitable access across geographically dispersed populations. Russia has substantial need for renal replacement therapy and urologic intervention across a large geography, with procurement, infrastructure, and localization considerations influencing device access. Brazil has a significant chronic kidney disease treatment burden and a large specialist base, supporting demand for dialysis technologies, endourology devices, and infection-control solutions. Mexico is expanding access to dialysis, urologic diagnostics, and minimally invasive procedures, with private-sector growth complementing public health services.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize clinically validated innovation that addresses measurable pain points in nephrology and urology care: infection reduction, treatment precision, procedure efficiency, patient comfort, home-care enablement, and long-term device reliability. Product development should align with clinician workflows, reimbursement realities, sterilization requirements, and evidence expectations across major regulatory systems. Devices that reduce complications, support remote monitoring, and improve usability for both specialists and patients are more likely to gain durable adoption.

Manufacturers should invest in interoperable digital architecture, cybersecurity-by-design, AI validation, and post-market data systems to support connected dialysis platforms, urodynamic systems, endoscopy solutions, and surgical technologies. Regional strategies should be tailored rather than uniform: mature markets require evidence, automation, and outcomes support, while emerging markets often prioritize affordability, maintenance simplicity, training, and supply reliability. Partnerships with hospitals, dialysis centers, academic clinicians, and public health programs can accelerate training, generate real-world evidence, and improve responsible adoption. Sustainability should also be embedded into design and procurement narratives, particularly for high-volume consumables and energy-intensive kidney care systems.

Research Methodology

This executive summary is developed using a structured secondary research approach focused on verified public health, regulatory, clinical, and industry sources. Inputs include peer-reviewed medical literature, clinical practice guidelines, public health agency publications, disease burden studies, regulatory frameworks, health technology assessment references, hospital procurement considerations, and documented trends in nephrology and urology care delivery. The analysis emphasizes evidence-backed drivers such as chronic kidney disease prevalence, diabetes and hypertension burden, population aging, urinary stone disease, infection prevention priorities, dialysis access, minimally invasive surgery adoption, and digital health integration.

The methodology excludes speculative market sizing, market share calculations, and forecasting. Instead, it synthesizes qualitative and evidence-based signals across device categories, regions, economic groups, and priority countries. Insights are reviewed for consistency with established clinical knowledge, regulatory direction, and healthcare system realities. Particular attention is given to regional access differences, reimbursement complexity, device safety requirements, AI governance, interoperability, and post-market evidence expectations in nephrology and urology devices.

Conclusion

Nephrology and urology devices are becoming central to modern healthcare as providers address the growing burden of kidney disease, urinary disorders, prostate conditions, stone disease, incontinence, and urologic cancers. The strongest opportunities are linked to safer procedures, earlier diagnosis, home-based kidney care, minimally invasive treatment, connected monitoring, AI-supported decision-making, and infection prevention. Regional adoption will continue to vary based on reimbursement, infrastructure, clinical workforce, regulation, and affordability, making localized strategies essential.

The industry's next phase will be shaped by evidence, usability, digital trust, regulatory readiness, and patient-centered design. Organizations that combine clinical performance with interoperability, service support, sustainable design, and region-specific access models will be best positioned to strengthen outcomes and support resilient nephrology and urology care systems worldwide.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. New Revenue Opportunities
  • 3.5. Next-Generation Business Models
  • 3.6. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Nephrology & Urology Devices Market, by Product

  • 7.1. Introduction
  • 7.2. Catheters
  • 7.3. Dialysis Devices
    • 7.3.1. CrRt Systems
    • 7.3.2. Hemodiafilters
    • 7.3.3. Hemodialysis Systems
    • 7.3.4. Peritoneal Dialysis Systems
  • 7.4. Endoscopes
  • 7.5. Lithotripsy Devices
  • 7.6. Ureteral Stents

8. Nephrology & Urology Devices Market, by Technology

  • 8.1. Introduction
  • 8.2. Acoustic Wave Technologies
  • 8.3. Electrochemical Technologies
  • 8.4. Laser Technologies
  • 8.5. Ultrafiltration Technologies

9. Nephrology & Urology Devices Market, by Distribution Channel

  • 9.1. Introduction
  • 9.2. Direct Sales
  • 9.3. Distributors
  • 9.4. Online Sales

10. Nephrology & Urology Devices Market, by Application

  • 10.1. Introduction
  • 10.2. Kidney Failure Management
  • 10.3. Kidney Stone Removal
  • 10.4. Prostate Disorders
  • 10.5. Urinary Incontinence Management

11. Nephrology & Urology Devices Market, by End User

  • 11.1. Introduction
  • 11.2. Ambulatory Surgical Centers
  • 11.3. Dialysis Centers
  • 11.4. Home Care Settings
  • 11.5. Hospitals

12. Nephrology & Urology Devices Market, by Region

  • 12.1. Asia-Pacific
  • 12.2. Europe
  • 12.3. North America
  • 12.4. Latin America
  • 12.5. Africa
  • 12.6. Middle East

13. Nephrology & Urology Devices Market, by Group

  • 13.1. NATO
  • 13.2. G7
  • 13.3. BRICS
  • 13.4. European Union
  • 13.5. ASEAN
  • 13.6. GCC

14. Nephrology & Urology Devices Market, by Country

  • 14.1. China
  • 14.2. United States
  • 14.3. Japan
  • 14.4. India
  • 14.5. Germany
  • 14.6. United Kingdom
  • 14.7. Australia
  • 14.8. France
  • 14.9. South Korea
  • 14.10. Italy
  • 14.11. Canada
  • 14.12. Russia
  • 14.13. Brazil
  • 14.14. Mexico
  • 14.15. Spain

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2025
  • 15.2. FPNV Positioning Matrix, 2025
  • 15.3. Market Concentration Analysis, 2025
    • 15.3.1. Concentration Ratio (CR)
    • 15.3.2. Herfindahl Hirschman Index (HHI)
  • 15.4. Recent Developments & Impact Analysis, 2025
  • 15.5. Product Portfolio Analysis, 2025
  • 15.6. Benchmarking Analysis, 2025

16. Company Profiles

  • 16.1. Ambu A/S
  • 16.2. AngioDynamics, Inc.
  • 16.3. Asahi Kasei Corporation
  • 16.4. B. Braun Melsungen AG
  • 16.5. Baxter International Inc.
  • 16.6. Becton, Dickinson and Company
  • 16.7. Biodex Medical Systems, Inc.
  • 16.8. Boston Scientific Corporation
  • 16.9. Coloplast A/S
  • 16.10. Convatec Group plc
  • 16.11. Cook Group Incorporated
  • 16.12. DirexGroup Ltd.
  • 16.13. EDAP TMS S.A.
  • 16.14. Fresenius Medical Care AG & Co. KGaA
  • 16.15. Hollister Incorporated
  • 16.16. Karl Storz SE & Co. KG
  • 16.17. Laborie Medical Technologies Corp.
  • 16.18. Lepu Medical Technology (Beijing) Co., Ltd.
  • 16.19. Medtronic plc
  • 16.20. Merit Medical Systems, Inc.
  • 16.21. Nipro Corporation
  • 16.22. Olympus Corporation
  • 16.23. Richard Wolf GmbH
  • 16.24. Siemens Healthineers AG
  • 16.25. Stryker Corporation
  • 16.26. Teleflex Incorporated
  • 16.27. Terumo Corporation
  • 16.28. Urovision GmbH

LIST OF FIGURES

  • FIGURE 1. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2025 VS 2032 (%)
  • FIGURE 7. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 23. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025

LIST OF TABLES

  • TABLE 1. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL CATHETERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL CATHETERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL CATHETERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL DIALYSIS DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL DIALYSIS DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL DIALYSIS DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL CRRT SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL CRRT SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL CRRT SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL HEMODIAFILTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL HEMODIAFILTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL HEMODIAFILTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL HEMODIALYSIS SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL HEMODIALYSIS SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL HEMODIALYSIS SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL PERITONEAL DIALYSIS SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL PERITONEAL DIALYSIS SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL PERITONEAL DIALYSIS SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ENDOSCOPES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ENDOSCOPES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ENDOSCOPES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL LITHOTRIPSY DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL LITHOTRIPSY DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL LITHOTRIPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL URETERAL STENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL URETERAL STENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL URETERAL STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ACOUSTIC WAVE TECHNOLOGIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ACOUSTIC WAVE TECHNOLOGIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ACOUSTIC WAVE TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ELECTROCHEMICAL TECHNOLOGIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ELECTROCHEMICAL TECHNOLOGIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ELECTROCHEMICAL TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL LASER TECHNOLOGIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL LASER TECHNOLOGIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL LASER TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ULTRAFILTRATION TECHNOLOGIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ULTRAFILTRATION TECHNOLOGIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ULTRAFILTRATION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL DIRECT SALES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL DIRECT SALES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL DIRECT SALES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL DISTRIBUTORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL DISTRIBUTORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL DISTRIBUTORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ONLINE SALES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL ONLINE SALES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ONLINE SALES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL KIDNEY FAILURE MANAGEMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL KIDNEY FAILURE MANAGEMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL KIDNEY FAILURE MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL KIDNEY STONE REMOVAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL KIDNEY STONE REMOVAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL KIDNEY STONE REMOVAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL PROSTATE DISORDERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL PROSTATE DISORDERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL PROSTATE DISORDERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL URINARY INCONTINENCE MANAGEMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL URINARY INCONTINENCE MANAGEMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL URINARY INCONTINENCE MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL DIALYSIS CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL DIALYSIS CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL DIALYSIS CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL HOME CARE SETTINGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL HOME CARE SETTINGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL HOME CARE SETTINGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. ASIA-PACIFIC NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. ASIA-PACIFIC NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 83. ASIA-PACIFIC NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DIALYSIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 84. ASIA-PACIFIC NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 85. ASIA-PACIFIC NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 86. ASIA-PACIFIC NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 87. ASIA-PACIFIC NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 88. EUROPE NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. EUROPE NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 90. EUROPE NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DIALYSIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPE NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPE NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 95. NORTH AMERICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. NORTH AMERICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 97. NORTH AMERICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DIALYSIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 98. NORTH AMERICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 99. NORTH AMERICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 100. NORTH AMERICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 101. NORTH AMERICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 102. LATIN AMERICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. LATIN AMERICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 104. LATIN AMERICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DIALYSIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 105. LATIN AMERICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 106. LATIN AMERICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 107. LATIN AMERICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 108. LATIN AMERICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 109. AFRICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 110. AFRICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 111. AFRICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DIALYSIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 112. AFRICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 113. AFRICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 114. AFRICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 115. AFRICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 116. MIDDLE EAST NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 117. MIDDLE EAST NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 118. MIDDLE EAST NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DIALYSIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 119. MIDDLE EAST NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 120. MIDDLE EAST NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 121. MIDDLE EAST NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 122. MIDDLE EAST NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 124. NATO NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 125. NATO NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 126. NATO NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DIALYSIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 127. NATO NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 128. NATO NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 129. NATO NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 130. NATO NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 131. G7 NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 132. G7 NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 133. G7 NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DIALYSIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 134. G7 NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 135. G7 NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 136. G7 NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 137. G7 NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 138. BRICS NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 139. BRICS NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 140. BRICS NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DIALYSIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 141. BRICS NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 142. BRICS NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 143. BRICS NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 144. BRICS NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPEAN UNION NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPEAN UNION NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPEAN UNION NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DIALYSIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPEAN UNION NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPEAN UNION NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPEAN UNION NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPEAN UNION NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 152. ASEAN NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 153. ASEAN NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 154. ASEAN NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DIALYSIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 155. ASEAN NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 156. ASEAN NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 157. ASEAN NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 158. ASEAN NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 159. GCC NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 160. GCC NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 161. GCC NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DIALYSIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 162. GCC NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 163. GCC NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 164. GCC NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 165. GCC NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 166. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 167. CHINA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 168. CHINA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 169. CHINA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DIALYSIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 170. CHINA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 171. CHINA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 172. CHINA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 173. CHINA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 174. UNITED STATES NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 175. UNITED STATES NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 176. UNITED STATES NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DIALYSIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 177. UNITED STATES NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 178. UNITED STATES NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 179. UNITED STATES NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 180. UNITED STATES NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 181. JAPAN NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 182. JAPAN NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 183. JAPAN NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DIALYSIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 184. JAPAN NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 185. JAPAN NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 186. JAPAN NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 187. JAPAN NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 188. INDIA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 189. INDIA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 190. INDIA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DIALYSIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 191. INDIA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 192. INDIA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 193. INDIA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 194. INDIA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 195. GERMANY NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 196. GERMANY NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 197. GERMANY NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DIALYSIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 198. GERMANY NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 199. GERMANY NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 200. GERMANY NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 201. GERMANY NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 202. UNITED KINGDOM NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 203. UNITED KINGDOM NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 204. UNITED KINGDOM NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DIALYSIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 205. UNITED KINGDOM NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 206. UNITED KINGDOM NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 207. UNITED KINGDOM NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 208. UNITED KINGDOM NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 209. AUSTRALIA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 210. AUSTRALIA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 211. AUSTRALIA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DIALYSIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 212. AUSTRALIA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 213. AUSTRALIA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 214. AUSTRALIA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 215. AUSTRALIA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 216. FRANCE NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 217. FRANCE NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 218. FRANCE NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DIALYSIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 219. FRANCE NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 220. FRANCE NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 221. FRANCE NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 222. FRANCE NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 223. SOUTH KOREA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 224. SOUTH KOREA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 225. SOUTH KOREA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DIALYSIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 226. SOUTH KOREA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 227. SOUTH KOREA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 228. SOUTH KOREA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 229. SOUTH KOREA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 230. ITALY NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 231. ITALY NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 232. ITALY NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DIALYSIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 233. ITALY NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 234. ITALY NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 235. ITALY NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 236. ITALY NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 237. CANADA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 238. CANADA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 239. CANADA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DIALYSIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 240. CANADA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 241. CANADA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 242. CANADA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 243. CANADA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 244. RUSSIA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 245. RUSSIA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 246. RUSSIA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DIALYSIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 247. RUSSIA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 248. RUSSIA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 249. RUSSIA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 250. RUSSIA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 251. BRAZIL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 252. BRAZIL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 253. BRAZIL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DIALYSIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 254. BRAZIL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 255. BRAZIL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 256. BRAZIL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 257. BRAZIL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 258. MEXICO NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 259. MEXICO NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 260. MEXICO NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DIALYSIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 261. MEXICO NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 262. MEXICO NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 263. MEXICO NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 264. MEXICO NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 265. SPAIN NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 266. SPAIN NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 267. SPAIN NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DIALYSIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 268. SPAIN NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 269. SPAIN NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 270. SPAIN NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 271. SPAIN NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 272. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • TABLE 273. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025